Cargando…
Targeting Chemoprevention of Colorectal Cancer to Those Who Are Likely to Respond
In the past four decades, chemoprevention of colorectal cancer (CRC) has been the subject of many epidemiologic and intervention trials of naturally occurring or pharmacologic agents. Recently, the positioning of cyclooxygenase 2 inhibitors as a viable option in this context was a major breakthrough...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Current Science Inc.
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817803/ https://www.ncbi.nlm.nih.gov/pubmed/20157367 http://dx.doi.org/10.1007/s11888-009-0041-6 |